Infantile polycystic disease of the kidneys.
D002675:Child, Preschool; D002740:Chlorothiazide / Q000627:therapeutic use; D005260:Female; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006977:Hypertension, Renal / Q000188:drug therapy; D007223:Infant; D007231:Infant, Newborn; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D007690:Polycystic Kidney Diseases / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D011433:Propranolol / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D014567:Urography
D006830:Hydralazine; D013148:Spironolactone; D008750:Methyldopa; D002740:Chlorothiazide; D011433:Propranolol; D006145:Guanethidine